Dr. Paul Alexander, the chief health equity and transformation officer at RWJBarnabas Health, has been named to the board of directors at New Jersey Community Capital, the state’s largest community development financial institution.
“We’re thrilled Dr. Alexander has joined our board. His knowledge and understanding of community health will greatly support the work NJCC is leading in the community and industry,” NJCC CEO Bernel Hall said. “Dr. Alexander’s expertise and experience working in health care and health insurance adds an invaluable perspective to our board. He’s committed to improving the quality of care and service delivered to underserved communities.”
Alexander said he’s eager to join the eight existing board members, including executives from JPMorgan Chase, BlackRock Alternative Investors, Wells Fargo, Hudson County Economic Development Corp., St. Joseph’s Carpenter Society of Camden and Rutgers Business School.
Alexander said he is eager to help support the organization’s mission and contribute to disadvantaged and underserved communities.
“The connection between financial status and health is a primary factor in improving (Black, indigenous and people of color) communities,” he said. “The absence of funding leads to poor health, which reduces the ability to get an education and to work, in turn, hindering the ability to be a community contributor.
“By joining NJCC, we can now better prepare underrepresented communities for the future by listening to them and addressing their needs through a holistic approach.”
About NJCC
New Jersey Community Capital is a nonprofit community development financial institution that provides an innovative toolkit of financial products, programs and services to advance equity and opportunity in underserved communities. NJCC supports the preservation and development of affordable housing and sustainable community development ventures that increase jobs, improve access to education and strengthen neighborhoods to ensure communities can thrive.
Alexander completed his undergraduate premedical studies and holds a Master of Public Health from Columbia University. He is a Case Western Reserve University School of Medicine graduate, a former Robert Wood Johnson clinical scholar at the University of Pennsylvania and a fellow of the Leonard Davis Institute at the Wharton School.
At RWJBH, he is responsible for the health system’s social mission, developing strategies to promote the health and wellness of the communities served, including employees.
Prior to joining RWJBH, Alexander was chief medical officer for government programs at Horizon Blue Cross Blue Shield of New Jersey and was instrumental in the advancement of quality of care and service delivered to New Jersey residents enrolled in Medicaid, Medicare or dual-eligible programs. He has held leadership positions at AstraZeneca Pharmaceuticals, UnitedHealthcare, Health Partners of Philadelphia and Independence Blue Cross.
